Type 1 protein tyrosine kinases in Chinese breast carcinomas: A Clinicopathologic Study

International Journal of Surgical Pathology

Volumn 9, Issue 3, 2001, Pages 177-187

  Suo, Zhenhe ^a   Yang, Huihua ^b   Mei, Qiang ^b   Skovlund, Eva ^a   Cui, Jianguo ^b   Nesland, Jahn M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Anyang Tumour Hospital   (China)

Author keywords

Breast carcinoma; c erbB 2; c erbB 3; c erbB 4; EGFR; Hormone receptor; Immunohistochemistry; Survival

Indexed keywords

C ERBB 3 PROTEIN; C ERBB 4 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GENE PRODUCT; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CHINA; DISEASE ASSOCIATION; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; ONCOGENE C ERB; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICS; SURVIVAL RATE; TUMOR VOLUME;

EID: 0034774660     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690100900303     Document Type: Article

References (67)

1. A thousand and one protein kinases
2. Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results
3. Signal transduction by receptors with tyrosine kinase activity
4. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
5. Growth factor receptor tyrosine kinases
6. Triggering signaling cascades by receptor tyrosine kinases
7. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
8. Biochemistry of the Src protein-tyrosine kinase: Regulation by SH2 and SH3 domains
9. Tyrosine kinase inhibition: An approach to drug development
10. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
11. Receptor protcin-tyrosine kinases and their signal transduction pathways
12. Nonreceptor tyrosine protein kinases
13. Non-receptor cytosolic protein tyrosine kinases from various rat tissues
14. Characterization of protein tyrosine kinases from human breast cancer: Involvement of the c-src oncogene product
15. Expression of pp60c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas
16. Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
17. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure
18. Epidermal growth factor receptor (EGFr); results of a 6-year follow-up study in operable breast cancer with emphasis on the node-negative subgroup
19. Epidermal growth factor receptor and other oncogenes as prognostic markers
20. Comparison of EGFR, c-erbB-2 product and fas p21 immunohistochemistry as prognostic markers in primary breast cancer
21. Prognosis of breast cancer: Evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes
22. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
23. Association of c-erbB2-gene amplification with poor prognosis in noninflammatory breast carcinomas but not in carcinomas of the inflammatory type
24. Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein
25. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer
26. c-erbB-3 protein expression in ductal carcinoma in situ of the breast
27. C-erbB-3 in human breast carcinoma: Expression and relation to prognosis and established prognostic indicators
28. Expression of the ERBB3 gene product in breast cancer
29. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma - An immunocytochemical study
30. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
31. Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior
32. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumor types
33. Type 1 protein tyrosine kinases in benign and malignant breast lesions
34. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
35. Epidermal growth factor receptors and estrogen receptors in human breast cancer
36. The prognostic value of epidermal growth factor receptor (EGFR) in breast cancer patients. Results of a follow-up study on 149 patients
37. Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients
38. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases
39. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
40. Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu
41. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study
42. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors
43. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer
44. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas
45. c-erbB-2 expression in primary gastric carcinomas and their metastases
46. The subcellular localization of the neu protein in human normal and neoplastic cells
47. Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens
48. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
49. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
50. The c-erbB-2 protein in primary and metastatic breast carcinomas
51. INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes
52. ErbB-4 mRNA expression is decreased in nonmetastatic pancreatic cancer
53. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro
54. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
55. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy
56. The value of estrogen and progesterone receptors in the treatment of breast cancer
57. Measurement of estrogen and progesterone receptors in human breast tumors: Enzyme immunoassay versus binding assay
58. Estrogen and progesterone receptors in cytology: A comprehensive review
59. Estrogen receptor functional status in human breast cancer
60. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer
61. Prognostic significance of HER-2 oncoprotein expression in breast cancer: A 30-year follow-up
62. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer
63. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
64. Prognostic importance of c-erbB-2 expression in breast cancer
65. c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study
66. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities
67. c-erbB-4 protein expression in human breast cancer